Correlation Between Visa and Oneness Biotech

Can any of the company-specific risk be diversified away by investing in both Visa and Oneness Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Oneness Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Oneness Biotech Co, you can compare the effects of market volatilities on Visa and Oneness Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Oneness Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Oneness Biotech.

Diversification Opportunities for Visa and Oneness Biotech

-0.7

Correlation Coefficient

Visa  Oneness Biotech

Excellent diversification

The 3 months correlation between Visa and Oneness is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Oneness Biotech Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oneness Biotech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Oneness Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oneness Biotech has no effect on the direction of Visa i.e., Visa and Oneness Biotech go up and down completely randomly.

Pair Corralation between Visa and Oneness Biotech

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.43 times more return on investment than Oneness Biotech. However, Visa Class A is 2.35 times less risky than Oneness Biotech. It trades about 0.17 of its potential returns per unit of risk. Oneness Biotech Co is currently generating about -0.11 per unit of risk. If you would invest  31,478  in Visa Class A on December 28, 2024 and sell it today you would earn a total of  3,508  from holding Visa Class A or generate 11.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	93.33%
Values	Daily Returns

Visa Class A  vs.  Oneness Biotech Co

Visa Class A

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Oneness Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oneness Biotech Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Visa and Oneness Biotech

The main advantage of trading using opposite Visa and Oneness Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Oneness Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oneness Biotech will offset losses from the drop in Oneness Biotech's long position.

The idea behind Visa Class A and Oneness Biotech Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.